Caregen
Financials
Valuation Metrics
Caregen's Market Cap is ₩3.5T. At end of 2025 it was ₩3.9T. Ranked #131 of 2,436 in KR market (top 5%), #17 of 1,649 on KOSDAQ (top 1%), #13 of 234 in Pharmaceuticals, Biotechnology & Life Sciences (top 6%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 3.45T KRW | KR#131/2,436 Sec#13/234 |
| Revenue | 74.22B KRW | KR#1,570/2,436 Sec#101/234 |
| Net Income | 23.36B KRW | KR#592/2,436 Sec#39/234 |
| Total Assets | 245.37B KRW | KR#1,136/2,436 Sec#79/234 |
| Net Assets | 214.47B KRW | KR#886/2,436 Sec#62/234 |
| Employees | 193 | KR#1,117/2,436 Sec#92/234 |
| Value | ||
| P/E | 147.83x | KR#1,460/2,436 Sec#98/234 |
| P/B | 16.10x | KR#2,377/2,436 Sec#216/234 |
| PEG | 3.82x | KR#827/2,436 Sec#56/234 |
| P/S | 46.54x | KR#2,365/2,436 Sec#195/234 |
| EV/EBITDA | 168.29x | KR#1,512/2,436 Sec#106/234 |
| FCF Yield | 0.43% | KR#1,181/2,436 Sec#88/234 |
| Profitability | ||
| ROE | 10.89% | KR#444/2,436 Sec#29/234 |
| ROA | 9.52% | KR#221/2,436 Sec#18/234 |
| Op. Margin | 27.55% | KR#72/2,436 Sec#14/234 |
| Revenue Growth | 6.63% | KR#1,092/2,436 Sec#100/234 |
| Earnings Growth | 38.72% | KR#631/2,436 Sec#37/234 |
| Financial Health | ||
| Debt Ratio | 114.41% | KR#533/2,436 Sec#71/234 |
| Total Debt | 0 KRW | KR—/2,436 Sec—/234 |
| FCF | 14.73B KRW | KR#605/2,436 Sec#32/234 |
| Cash | 13.16B KRW | KR#1,505/2,436 Sec#112/234 |
| Current Ratio | 4.80x | KR#309/2,436 Sec#59/234 |
| Net Debt/EBITDA | -0.64x | KR#545/2,436 Sec#33/234 |
| Dividend | ||
| Div. Yield | 0.74% | KR#1,229/2,436 Sec#77/234 |
| Div. Growth | -31.72% | KR—/2,436 Sec—/234 |
| Performance | ||
| 1Y Return | 35.37% | KR#314/2,436 Sec#28/234 |
| 1M Return | -6.13% | KR#1,485/2,436 Sec#147/234 |
| From 52W High | -58.19% | KR#1,620/2,436 Sec#138/234 |
| 1Y MDD | -67.16% | KR#1,802/2,436 Sec#148/234 |
| Trading | ||
| Volume | 111,655 shares | KR#877/2,436 Sec#87/234 |
| Foreign Own. | 4.42% | KR#845/2,436 Sec#80/234 |
| Per Share | ||
| EPS | 435 KRW | KR#965/2,436 Sec#68/234 |
| BPS | 4,388 KRW | KR#1,549/2,436 Sec#115/234 |
Company Info
Caregen, established in 2001 and listed on KOSDAQ in 2015, is a biotechnology company headquartered in Gangnam-gu, Seoul. It researches and develops peptides and growth factor proteins, selling professional therapy products, functional cosmetics, and health functional foods in 130 countries. The company has built a peptide library with 833 domestic and international patent registrations and is developing new drug pipelines for conditions like macular degeneration, diabetes, and hair loss. Caregen is also expanding its business into new areas such as specialized animal pharmaceuticals and functional feeds.